JAZZ Venture Partners
Edit

JAZZ Venture Partners

https://jazzvp.com
Last activity: 22.07.2026
Active
Invests in categories: AIArtificial IntelligenceGamingHealthTechHumanLearnMedtechPlatformSoftwareTechnology
JAZZ Venture Partners invests in technologies that improve human performance
Portfolio
59
Mentions
46
Investment Type: Venture Capital
Investment Stage: Series B

Portfolio 59

DateNameWebsiteTotal RaisedLocation
22.07.2026Transcript...transcriptabio.com$24MUnited Sta...
17.05.2023Cadence Ne...cadenceneuro.com$41MUnited Sta...
15.05.2023Zus Healthzushealth.com$74MCanada, Sa...
13.10.2022Virbvirb.io$2MUnited Sta...
13.10.2022Enveda Bio...envedabio.com$577.9MUnited Sta...
13.10.2022Form Bioformbio.com$30M-
23.07.2022Arrive Hea...arrivehealth.com-United Sta...
23.07.2022Rarebase, ...rarebase.org-United Sta...
23.07.2022Augment AIaugment.co$85MUnited Sta...
07.03.2022Her M.D.hermdhealth.com$28MUnited Sta...
Show more

Mentions in press and media 46

DateTitleDescription
27.07.2026Transcripta Bio Secures $24 Million to Accelerate AI Drug Discovery for Neurological DiseasesTranscripta Bio announced a significant $24 million capital raise. This funding, secured since its Series A, propels the company's AI-driven drug discovery platform. The Palo Alto firm targets neurological and neuromuscular diseases. New ca...
22.07.2026Transcripta Bio Raises $24 Million To Advance AI-Powered Neurological Drug PipelineTranscripta Bio has raised $24 million since its Series A financing to advance an AI-powered drug discovery platform focused on neurological and neuromuscular diseases. New investors Mayo Clinic and Omnimed joined existing backers JAZZ Vent...
22.07.2026Transcripta Bio Announces $24 Million Funding PALO ALTO, CA, Transcripta Bio, an AI-powered drug discovery company focused on neurological and neuromuscular diseases, announced it has raised $24 million since its Series A. >> Click here for more funding data on Transcripta Bio &...
19.06.2024Enveda Biosciences: $55 Million Closed To Use AI For Translating Nature Into New MedicinesEnveda Biosciences, a biotechnology company that utilizes AI to translate nature into new medicines, announced a new funding round of $55 million to add to its $119 million combined Series B and B1. The new investors, Premji Invest, Lingott...
17.06.2024Enveda Biosciences: Revolutionizing Drug Discovery Through the Power of AIEnveda Biosciences, a dynamic biotechnology company hailing from the vibrant city of Boulder, Colorado, is making significant strides in the field of drug discovery by harnessing the transformative potential of artificial intelligence (AI)....
16.06.2024Enveda Biosciences Raises $55M in FundingEnveda Biosciences, a Boulder, CO-based biotechnology company using AI to translate nature into new medicines, raised a new financing round of $55m to add to its $119m combined Series B and B1. New investors Premji Invest, Lingotto Investme...
29.04.2024Transcripta Bio: $10 Million Raised To Speed Up Drug Discovery With Lower RiskTranscripta Bio, a company focused on drug discovery at unprecedented speed and scale, with lower risk and higher certainty across multiple diseases in parallel, announced its launch with $10 million in funding. Transcripta Bio co-founder, ...
05.09.2023How Today’s Most Innovative Investors Are Shaking Up Venture CapitalMariam Naficy, founder of Heretic Ventures (Photo by JP Yim/Getty Images for Tonic.xyz)Getty Images for Tonic.xyz
01.08.2023HerMD Snags $18M to Open More Menopause-Focused Health CentersEven though more than 1 million women across the U.S. undergo menopause each year, only 20% of OB/GYNs receive training on how to address questions related to this natural transition in life or how to treat complications arising from it. He...
31.07.2023HerMD raises $18M led by Jazz Venture Partners to expand brick-and-mortar footprint, grow team-
Show more

Reviews 0

Sign up to leave a review

Sign up Log In